Effects of Escitalopram and Bupropion on Oxidative Stress Parameters and Blood Count Findings in Female Rats

dc.authorscopusid 16174494200
dc.authorscopusid 57193334079
dc.authorscopusid 54893403000
dc.authorscopusid 56414216300
dc.contributor.author Arihan, Okan
dc.contributor.author Ergül Erkeç, Ozlem
dc.contributor.author Doǧan, Abdulahad
dc.contributor.author Yıldırım, Abdullah
dc.date.accessioned 2025-09-30T16:35:27Z
dc.date.available 2025-09-30T16:35:27Z
dc.date.issued 2025
dc.department T.C. Van Yüzüncü Yıl Üniversitesi en_US
dc.department-temp [Arihan] Okan, Department of Physiology, Hacettepe Üniversitesi, Ankara, Turkey; [Ergül Erkeç] Ozlem, Department of Physiology, Van Yüzüncü Yıl Üniversitesi, Van, Turkey; [Doǧan] Abdulahad, Department of Biochemistry, Van Yüzüncü Yıl Üniversitesi, Van, Turkey; [Yıldırım] Abdullah, Department of Psychiatry, KSU Medical School, Kahramanmaras, Turkey en_US
dc.description.abstract In this study, the effects of two antidepressants with different mechanisms on rat blood oxidative stress parameters and blood count findings were studied. Escitalopram is a selective serotonin reuptake blocker (SSRI) derivative and bupropion has a mechanism of action on noradrenaline and dopamine and increases their synaptic amount by inhibiting their uptake. Adult, female, Wistar-albino rats were divided into 3 different groups with a total of 24 animals. Rats in escitalopram group were administered with 20 mg/kg/day escitalopram and rats in the bupropion group were administered with 20 mg/kg/day bupropion for 28 days via gastric gauge. The rats in the control group were given tap water via gastric gauge. Hematocrit and hemoglobin parameters were significantly higher in Escitalopram and Bupropion than control group. No significant difference was observed in weight gain at the end of 28 days. In this experimental model, 28 days of 20 mg/kg escitalopram or bupropion use did not cause a significant increase in total oxidant status or a significant decrease in total antioxidant status. Oxidative stress index which combines these two findings imply a possible oxidative stress in female rat blood due to Escitalopram treatment. © 2025 Elsevier B.V., All rights reserved. en_US
dc.identifier.doi 10.5505/ejm.2025.81073
dc.identifier.endpage 366 en_US
dc.identifier.issn 1309-3886
dc.identifier.issn 1301-0883
dc.identifier.issue 3 en_US
dc.identifier.scopus 2-s2.0-105014952074
dc.identifier.scopusquality Q4
dc.identifier.startpage 361 en_US
dc.identifier.uri https://doi.org/10.5505/ejm.2025.81073
dc.identifier.uri https://hdl.handle.net/20.500.14720/28560
dc.identifier.volume 30 en_US
dc.identifier.wosquality N/A
dc.language.iso en en_US
dc.publisher Yuzuncu Yil Universitesi Tip Fakultesi en_US
dc.relation.ispartof Eastern Journal of Medicine en_US
dc.relation.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.subject Antidepressant en_US
dc.subject Bupropion (Amfebutamone) en_US
dc.subject Depression en_US
dc.subject Escitalopram en_US
dc.subject Noradrenaline en_US
dc.subject SSRI en_US
dc.subject Hemoglobin en_US
dc.subject Ketamine en_US
dc.subject Xylazine en_US
dc.subject SPSS 20.0 for Windows en_US
dc.subject Antidepressant Agent en_US
dc.subject Animal Experiment en_US
dc.subject Article en_US
dc.subject Biochemical Analysis en_US
dc.subject Blood Cell Count en_US
dc.subject Blood Sampling en_US
dc.subject Controlled Study en_US
dc.subject Drug Effect en_US
dc.subject Erythrocyte Count en_US
dc.subject Female en_US
dc.subject Hematocrit en_US
dc.subject Nonhuman en_US
dc.subject Oxidative Stress en_US
dc.subject Parameters en_US
dc.subject Rat en_US
dc.subject Spectrophotometry en_US
dc.subject Total Antioxidant Capacity en_US
dc.subject Wistar Rat en_US
dc.title Effects of Escitalopram and Bupropion on Oxidative Stress Parameters and Blood Count Findings in Female Rats en_US
dc.type Article en_US
dspace.entity.type Publication

Files